Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether/Lumefantrine in Vivax Malaria
NCT01625871Phase 3Completed
- Sponsor
- University of Khartoum
- Start
- Sep 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of artemether, lumefantrine in Plasmodium vivax malaria, sponsored by University of Khartoum. Started Sep 2011; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
Plasmodium vivax malaria
Beyond the preview
Go deeper on NCT01625871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01625871.